October 15th 2024
Chris Ryan
The FDA has approved Optune Lua for concurrent use with PD-1/PD-L1 inhibitors or docetaxel in metastatic non–small cell lung cancer.
October 15th 2024
Fox Chase Cancer Center
A new study from researchers at Fox Chase Cancer Center has found that some ossifying fibromyxoid tumors are malignant sarcomas.
October 15th 2024
Ashling Wahner
Jacqueline Brown, MD, discusses the nuanced potential role of immunotherapy-ADC and dual-ADC combinations in bladder cancer.
October 15th 2024
Chris Ryan
The FDA has granted orphan drug designation to IMM-1-104 for pancreatic cancer.
October 15th 2024
Ashling Wahner
LP-184 has received fast track designation from the FDA for the treatment of patients with glioblastoma.